SCHEMBL5582576

SCHEMBL5582576

CN(CC1=Cc2ccc(N)cc2CC1)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 4/20 0.43
ACHE P22303 1/20 0.40
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
PRMT8 Q9NR22 1/20 0.40
GRIN2B Q13224 1/20 0.39
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
AOC3 Q16853 1/20 0.37
TSHR P16473 2/20 0.36
LMNA P02545 2/20 0.36
USP2 O75604 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
PYCR1 P32322 1/20 0.36
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582583 0.84 MCHR1 (0.46) MCHR1
SCHEMBL5582506 0.76 MCHR1 (0.39) MCHR1
SCHEMBL5582744 0.72 MCHR1 (0.41) MCHR1KDM4EGAAMAPT
SCHEMBL3152066 0.72 CARM1 (0.59) ACHECARM1PRMT6PRMT8ALDH1A1
SCHEMBL28195590 0.71 MCHR1 (0.52) MCHR1
SCHEMBL6675561 0.71 MAOB (0.57) ACHECARM1PRMT6PRMT8ALDH1A1
SCHEMBL14454757 0.70 MCHR1 (0.53) MCHR1ALDH1A1AOC3
SCHEMBL5582920 0.70 MCHR1 (0.34) MCHR1ACHEALDH1A1KDM4ESMN1; SMN2
Dibemethine SCHEMBL10542007 0.68 ALDH1A1 (0.70) CARM1PRMT6PRMT8ALDH1A1KDM4E
Dibemethine SCHEMBL276863 0.68 ALDH1A1 (0.70) CARM1PRMT6PRMT8ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-7115750-B1 Melanin concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173498-A1 Melanin concentrating hormone antagonist MC1R, MCHR1, MCHR2 MCHR1 2/4885ACHE 4858/4885CARM1 3008/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.